ICP | Innovators Commercialisation Program

ICP | Innovators Commercialisation Program is dedicated to accelerating the development and commercialization of innovative medical equipment. Located in Singapore, ICP | Innovators Commercialisation Program focuses on supporting health tech, Medtech, diagnostic, and biotech startups through its comprehensive 6-month commercialization program.

ICP | Innovators Commercialisation Program collaborates with leading healthcare professionals and clinicians to offer crucial clinical validation and venture-building support. This enables businesses to expand into Singapore and the broader region. With a focus on improving users' lifespans and quality of life, enabling seamless delivery of high-quality healthcare, digitalizing hospital systems, and enhancing women's and children's health outcomes, ICP | Innovators Commercialisation Program is at the forefront of medical innovation.

Operating from its primary address in Singapore, ICP | Innovators Commercialisation Program provides access to venture investment and facilitates fast-track clinical adoption and trials across Asia. ICP | Innovators Commercialisation Program is committed to driving advancements in the medical field. We invite the management team of ICP | Innovators Commercialisation Program to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and offerings.